Achieve Life Sciences (ACHV) Other Operating Expenses (2010 - 2026)

Achieve Life Sciences (ACHV) posted Other Operating Expenses of $341000.0 for Q1 2026, up 610.42% on a QoQ basis from $48000.0 in Q4 2025.

Achieve Life Sciences (ACHV) Other Operating Expenses (2010 - 2026) Analysis & Trends

Achieve Life Sciences' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $341000.0 for Q1 2026.

Quarterly Other Operating Expenses changed N/A year-over-year to $341000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $389000.0 (changed N/A YoY) and the FY2025 annual result came in at $48000.0, changed N/A from the prior year.
Other Operating Expenses was $341000.0 for Q1 2026 at Achieve Life Sciences, up from $48000.0 in the prior quarter.
Across five years, Other Operating Expenses topped out at $341000.0 in Q1 2026 and bottomed at $48000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Achieve Life Sciences	326.16 Mn	326.16 Mn	-

Download Data